Skip to content

Drug interactions

Elvitegravir / cobicistat / emtricitabine / tenofovir df + Lacosamide

Severity: Minor

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Lacosamide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cobicistat is a strong CYP3A4 inhibitor, but lacosamide relies on CYP3A4 only minimally. Any increase in exposure is expected to be small, though cobicistat can also affect PR interval at higher exposures.

What this interaction means in plain words

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Lacosamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Cobicistat inhibits CYP3A4, slightly reducing lacosamide metabolism.

What to do

No routine dose adjustment is needed. Monitor for dizziness and conduction symptoms, particularly in renal or hepatic impairment or with other PR-prolonging drugs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elvitegravir / cobicistat / emtricitabine / tenofovir df and Lacosamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elvitegravir / cobicistat / emtricitabine / tenofovir df with Lacosamide?

MediHelp rates the interaction as minor. Elvitegravir / cobicistat / emtricitabine / tenofovir df and Lacosamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Cobicistat is a strong CYP3A4 inhibitor, but lacosamide relies on CYP3A4 only minimally. Any increase in exposure is expected to be small, though cobicistat can also affect PR interval at higher exposures.

How serious is the interaction between Elvitegravir / cobicistat / emtricitabine / tenofovir df and Lacosamide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose adjustment is needed. Monitor for dizziness and conduction symptoms, particularly in renal or hepatic impairment or with other PR-prolonging drugs.

What other medicines interact with Lacosamide?

MediHelp also lists interactions of Lacosamide with, for example, Zuranolone, Atazanavir, Carbamazepine. The full list is on the Lacosamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in